Citadel Advisors’s Aptevo Therapeutics APVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-151
| Closed | -$20.1K | – | 5951 |
|
|
2024
Q3 | $20.1K | Buy |
+151
| New | +$20.1K | ﹤0.01% | 5335 |
|
|
2024
Q1 | – | Sell |
-8
| Closed | -$47.4K | – | 6082 |
|
|
2023
Q4 | $47.4K | Buy |
+8
| New | +$47.4K | ﹤0.01% | 5137 |
|
|
2023
Q3 | – | Hold |
0
| – | -$18.7K | – | 5849 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5271 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$97.6K | – | 5892 |
|
|
2022
Q4 | $97.6K | Hold |
1
| – | – | ﹤0.01% | 5029 |
|
|
2022
Q3 | $51K | Buy |
+1
| New | +$51K | ﹤0.01% | 5305 |
|
|
2018
Q3 | – | Hold |
0
| – | -$61K | – | 4253 |
|
|
2018
Q2 | – | Hold |
0
| – | -$130K | – | 3889 |
|
|
2018
Q1 | – | Hold |
0
| – | -$53K | – | 3590 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3613 |
|